Journal of Korean Neurosurgical Society

  • 제54권2호
  • /
  • Pages.107-111
  • /
  • 2013
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

The Usefulness of Stereotactic Radiosurgery for Radioresistant Brain Metastases

  • Kim, Hyool (Department of Neurosurgery, Brain Tumor Clinic & Gamma Knife Center and Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Jung, Tae-Young (Department of Neurosurgery, Brain Tumor Clinic & Gamma Knife Center and Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Kim, In-Young (Department of Neurosurgery, Brain Tumor Clinic & Gamma Knife Center and Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Jung, Shin (Department of Neurosurgery, Brain Tumor Clinic & Gamma Knife Center and Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Moon, Kyung-Sub (Department of Neurosurgery, Brain Tumor Clinic & Gamma Knife Center and Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Park, Seung-Jin (Department of Biomedical Engineering, Brain Tumor Clinic & Gamma Knife Center and Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School)
  • 투고 : 2012.11.22
  • 심사 : 2013.08.17
  • 발행 : 2013.08.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : We investigated the effectiveness of stereotactic gamma knife Radiosurgery (GKR) for radioresistant brain metastases with the impact upon histology. Methods : Between April 2004 and May 2011, a total of 23 patients underwent GKR for 67 metastatic brain tumors from 12 renal cell cancers, 5 sarcomas and 6 melanomas. The mean age was 56 years (range, 18 to 79 years). Most of the patients were classified as the Radiation Therapy Oncology Group recursive partitioning analysis class II (91.3%). The synchronous metastasis was found in 6 patients (26.1%) and metachronous metastasis in 17 patients (73.9%). We analyzed the local control rate, intracranial progression-free survival (PFS) and overall survival (OS). Results : The mean tumor volume for GKR was 2.24 cc and the mean prescription dose was 19.4 Gy (range, 10 to 24) to the tumor margin. Out of metachronous metastases, the median duration to intracranial metastasis was 3.3 years in renal cell cancer (RCC), 2.4 years in melanoma and 1.1 years in sarcoma (p=0.012). The total local control rate was 89.6% during the mean 12.4 months follow-up. The six-month and one-year local control rate was 90.2% and 83% respectively. Depending on the pathology, the control rate of RCC was 95.7%, sarcoma 91.3% and melanoma 80.5% during the follow-up. The common cause of local failure was the tumor bleeding in melanoma. The median PFS and OS were 5.2 and 8.4 months in RCC patients, 6.5 and 9.8 months in sarcoma, and 3.8 and 5.1 months in melanoma. Conclusion : The GKR can be one of the effective management options for the intracranial metastatic tumors from the radioresistant tumors. The melanoma showed a poor local control rate compared to other pathologies because of the hemorrhage.

키워드

참고문헌

  1. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL : Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 51 : 656-665; discussion 665-667, 2002
  2. Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A, et al. : Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery 56 : 936-945; discussion 936-945, 2005
  3. Clarke JW, Register S, McGregor JM, Grecula JC, Mayr NA, Wang JZ, et al. : Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis. Am J Clin Oncol 33 : 70-74, 2010 https://doi.org/10.1097/COC.0b013e31819ccc8c
  4. Coia LR : The role of radiation therapy in the treatment of brain metastases. Int J Radiat Oncol Biol Phys 23 : 229-238, 1992 https://doi.org/10.1016/0360-3016(92)90567-2
  5. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. : Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 : 745-751, 1997 https://doi.org/10.1016/S0360-3016(96)00619-0
  6. Hoskin PJ, Crow J, Ford HT : The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 19 : 111-115, 1990
  7. Larson DA, Gutin PH, Leibel SA, Phillips TL, Sneed PK, Wara WM : Stereotaxic irradiation of brain tumors. Cancer 65 (3 Suppl) : 792-799, 1990 https://doi.org/10.1002/1097-0142(19900201)65:3+<792::AID-CNCR2820651327>3.0.CO;2-P
  8. Manon R, O'Neill A, Knisely J, Werner-Wasik M, Lazarus HM, Wagner H, et al. : Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma : an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 23 : 8870-8876, 2005 https://doi.org/10.1200/JCO.2005.01.8747
  9. Mehta M, Noyes W, Craig B, Lamond J, Auchter R, French M, et al. : A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys 39 : 445-454, 1997 https://doi.org/10.1016/S0360-3016(97)00071-0
  10. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. : A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 : 494-500, 1990 https://doi.org/10.1056/NEJM199002223220802
  11. Penar PL, Wilson JT : Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation. Neurosurgery 34 : 888-893; discussion 893-894, 1994 https://doi.org/10.1227/00006123-199405000-00016
  12. Petrovich Z, Yu C, Giannotta SL, O'Day S, Apuzzo ML : Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 97 (5 Suppl) : 499-506, 2002
  13. Powell JW, Chung CT, Shah HR, Canute GW, Hodge CJ, Bassano DA, et al. : Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg 109 Suppl : 122-128, 2008
  14. Redmond AJ, Diluna ML, Hebert R, Moliterno JA, Desai R, Knisely JP, et al. : Gamma Knife surgery for the treatment of melanoma metastases : the effect of intratumoral hemorrhage on survival. J Neurosurg 109 Suppl : 99-105, 2008
  15. Rutigliano MJ, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M : The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 37 : 445-453; discussion 453-455, 1995 https://doi.org/10.1227/00006123-199509000-00012
  16. Sin AH, Cardenas RJ, Vannemreddy P, Nanda A : Gamma Knife stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers : outcome analysis of survival and control of brain disease. South Med J 102 : 42-44, 2009 https://doi.org/10.1097/SMJ.0b013e318189acd3
  17. Wrónski M, Maor MH, Davis BJ, Sawaya R, Levin VA : External radiation of brain metastases from renal carcinoma : a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 37 : 753-759, 1997 https://doi.org/10.1016/S0360-3016(97)00006-0

피인용 문헌

  1. Stereotactic radiosurgery for multiple brain metastases vol.14, pp.10, 2013, https://doi.org/10.1586/14737140.2014.940325
  2. Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases vol.58, pp.3, 2013, https://doi.org/10.3340/jkns.2015.58.3.217
  3. The Energy Index Does Not Affect Local Control of Brain Metastases Treated by Gamma Knife Stereotactic Radiosurgery vol.77, pp.1, 2015, https://doi.org/10.1227/neu.0000000000000750
  4. Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery vol.124, pp.3, 2013, https://doi.org/10.1007/s11060-015-1871-5
  5. Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours vol.143, pp.7, 2013, https://doi.org/10.1007/s00432-017-2373-y
  6. Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11 C-methionine uptak vol.7, pp.None, 2017, https://doi.org/10.1186/s13550-017-0293-0
  7. Malignant Melanoma: Diagnostic and Management Update vol.142, pp.2, 2018, https://doi.org/10.1097/prs.0000000000004571